AI NewsA COVID Vaccine Stock on the S&P 500 Is Up 600% This...

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

The AI boom has driven the 2026 stock market, but the S&P 500’s best performer so far this year is not a chipmaker. It is a COVID vaccine maker, up 663% after closing at $225 on Friday.

That lead rests on a cancer vaccine trial whose detailed results have not been released. In mid-August, the company’s shares were still down nearly 90% from their pandemic peak.

How Moderna Stock Climbed Past Every AI Name

The company is Moderna (MRNA), best known for its COVID shot. On August 19, it and drugmaker Merck said their experimental cancer vaccine had passed a final-stage trial in skin cancer patients.

The news landed after a rough stretch. COVID vaccine sales had collapsed, and Moderna cut more than 800 jobs last year.

Shares closed up 177% that day, then fell 24% the next, according to the Inquirer. BeInCrypto had already flagged Moderna’s 2026 comeback in June, when the stock was up 125% on a flu vaccine approval.

On Friday, the gains extended, with Moderna rejoining the Nasdaq-100, an index of Nasdaq’s largest non-financial companies.

More than 200 funds holding over $800 billion track it, Nasdaq said, so they had to buy the shares.

The same day, The New York Times reported a COVID-style national cancer vaccine push, expected to launch in December. Moderna closed 14% higher.

AI names sit just behind. SanDisk, which sells memory chips to AI data centers, is up 566% this year, riding AI memory chip demand. The S&P 500 has gained about 14%.

October Is Critical For Moderna Stock Price

So far, Moderna and Merck have said the vaccine worked but have not shown how well. Investors get the full numbers on October 24, at a major cancer conference in Madrid.

“It provides proof of principle that personalised cancer vaccines work,” Marco Gerlinger, a professor at Barts Cancer Institute, told the Pharmaceutical Journal.

Notably, not every investor is buying the rally. Martin Shkreli, a former drug company executive, gives the Moderna stock bubble up to six months to burst.

Moderna is now worth about $89.8 billion, and rivals BioNTech and Genentech are testing a cancer vaccine of their own.

- Advertisement -spot_img

More From UrbanEdge

Kraken Parent’s Profit Rebound Still Leaves a Wide Gap Before Its IPO

Kraken parent Payward said clients kept adding assets for 12 straight months, even as those holdings lost dollar value. Its adjusted earnings rose to $60 million in the third quarter, up from $23 million in the second. However, that was still 67% below a year earlier, Bloomberg reported, citing a shareholder letter. These are its…

AMD Just Had Its Biggest Run Against Nvidia Since 1999. Can It Survive Earnings?

AMD outperformed Nvidia by 53.2 percentage points over five trading days, according to The Kobeissi Letter. That is the widest gap between the two chipmakers since Nvidia went public in January 1999. That lead met its first test on Friday, when AMD stock fell 8.75%. Nvidia’s November 17 earnings report now sets up the next…

Charles Hoskinson Clashes With Angry ADA Holders Over Promises of Price Gains

Cardano founder Charles Hoskinson says he never promised that ADA would rise. He made the remarks during a heated livestream with frustrated investors. His comments come as ADA trades near multi-year lows, far below highs from previous cycles. Hoskinson Says Cardano’s Roadmap Is Complete Cardano’s roadmap is a five-era development plan that guided the network…

House Memo Targets Officials’ Prediction Market Bets

House Oversight staff want Congress to curb officials’ prediction market bets, at least on government actions and political outcomes. The November 13 memo aims those limits at officials who trade, leaving the platforms’ business intact.  The size of that business shows in Robinhood’s results. The broker’s event contracts revenue rose more than sixfold year over…

Hyperliquid’s HYPE Token Shows Resilience as Crypto Market Crash Deepens

Hyperliquid’s HYPE token has lost roughly a quarter of its value since its peak. Yet amid the latest crypto market crash, it is holding up better than Bitcoin and Ethereum. Its derivatives market offers one possible explanation. HYPE traded near $73 on Friday, down approximately 7% over seven days. Bitcoin lost more than 9% during…

XRP ETF Outflows Hit an 8-Month High. December Rarely Brings Relief

US spot XRP ETFs lost $19.13 million in the week ending November 13. It was their largest weekly outflow in 8 months, and it came as the altcoin fell below $1.00. The funds have now posted 2 straight weeks of outflows. XRP has also lost 20% so far in November, CryptoRank data shows. Past Decembers…

Will AI Agents Pay for News and Media Content Soon?

BeInCrypto's CEO asked whether AI agents will pay for news. BeInCrypto Research's x402 data shows agents already pay for information, but mostly in fractions of a cent. The post Will AI Agents Pay for News and Media Content Soon? appeared first on BeInCrypto.

Big Banks Have Nearly $1 Trillion Tied to AI. What If the Boom Cracks?

The largest US bank holding companies have close to $1 trillion in exposure to firms behind the AI buildout. The Federal Reserve (Fed) disclosed the figure in its November Financial Stability Report. The Fed still describes the banking system as sound, with high capital ratios. Yet 87% of market contacts surveyed by the New York…

Metaplanet Cuts 2026 Revenue Target 59%: Is the Bitcoin Playbook Running Dry?

Metaplanet cut its 2026 revenue forecast by 59% on November 13, to ¥6.5 billion from ¥16 billion. Its operating profit forecast fell 74%, to ¥3 billion from ¥11.4 billion. The Tokyo-listed Bitcoin (BTC) treasury firm traced the cut to its own discounted stock. Metaplanet stock fell 4.37% to ¥219 that day, down 53.21% so far…
- Advertisement -spot_img